CNS Pharmaceuticals logo

CNS Pharmaceuticals CNSP

$ 4.44 6.22%
report update icon

Quarterly report 2026-Q3
added 11-16-2026

Country

usaUSA

IPO year

2019

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

Shares

443 K

Market Cap[1]

$ 1.97 M

EBITDA (LTM)

$ -16.3 M

P/E (LTM)

-0.18539

P/S (LTM)

-

EPS (LTM)

-18.07

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Shattuck Labs Shattuck Labs
STTK
$ 4.48 -2.4 % $ 312 M Nasdaq Global Select Market usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
$ 19.82 0.08 % $ 2.81 B Nasdaq Global Select Market britainBritain
Soligenix Soligenix
SNGX
$ 0.25 -10.34 % $ 1.3 M Nasdaq Capital Market usaUSA
Sanofi Sanofi
SNY
$ 47.19 -0.73 % $ 57.6 B Nasdaq Global Select Market franceFrance
Spruce Biosciences Spruce Biosciences
SPRB
$ 40.66 0.42 % $ 31.2 M Nasdaq Global Select Market usaUSA
Spero Therapeutics Spero Therapeutics
SPRO
$ 0.87 -3.47 % $ 48.7 M Nasdaq Global Select Market usaUSA
Sarepta Therapeutics Sarepta Therapeutics
SRPT
$ 14.54 -1.56 % $ 1.46 B Nasdaq Global Select Market,SPB usaUSA
Savara Savara
SVRA
$ 4.7 4.8 % $ 1.05 B Nasdaq Global Select Market usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
- -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
- - $ 2.91 B Nasdaq Global Select Market usaUSA
Sutro Biopharma Sutro Biopharma
STRO
$ 8.47 -5.04 % $ 72 M Nasdaq Global Select Market usaUSA
Tarsus Pharmaceuticals Tarsus Pharmaceuticals
TARS
$ 75.97 -2.85 % $ 3.17 B Nasdaq Global Select Market usaUSA
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
$ 36.28 1.88 % $ 2.05 B Nasdaq Global Select Market,SPB usaUSA
TG Therapeutics TG Therapeutics
TGTX
$ 66.13 5.45 % $ 9.54 B Nasdaq Capital Market usaUSA
Aphria Inc. Aphria Inc.
APHA
- -0.45 % $ 4.87 B Nasdaq Global Select Market canadaCanada
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
- -0.90 % $ 104 M Nasdaq Capital Market usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
- -6.00 % $ 238 M Nasdaq Global Select Market usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
- - $ 376 M Nasdaq Global Market usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
- 0.38 % $ 12.9 M Nasdaq Global Select Market israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
- 2.07 % $ 34.4 M Nasdaq Capital Market usaUSA
Cerecor Inc. Cerecor Inc.
CERC
- -1.68 % $ 283 M Nasdaq Capital Market usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
- - $ 1.63 B Nasdaq Global Select Market usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
- -1.77 % $ 39.2 M Nasdaq Capital Market bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
- 0.34 % $ 2.98 B Nasdaq Global Select Market,SPB usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
- 1.3 % $ 27.7 M Nasdaq Global Select Market franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
- - $ 6.81 B Nasdaq Global Select Market britainBritain
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
- - $ 1.7 B Nasdaq Global Select Market usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
- - $ 256 M Nasdaq Global Market canadaCanada
argenx SE argenx SE
ARGX
$ 940.88 -0.7 % $ 57.7 B Nasdaq Global Select Market niderlandNiderland
Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Holding Corp.
TNXP
$ 2.86 -4.25 % $ 24.3 M Nasdaq Global Select Market usaUSA
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
- -2.54 % $ 57.2 M Nasdaq Global Market usaUSA
Xenetic Biosciences Xenetic Biosciences
XBIO
$ 1.52 -5.59 % $ 2.59 M Nasdaq Capital Market usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
- -3.18 % $ 58.5 M Nasdaq Global Select Market usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
- -2.25 % $ 31.3 M Nasdaq Global Select Market danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
- -10.74 % $ 89.9 M Nasdaq Global Select Market usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
- - $ 1.77 B Nasdaq Global Select Market usaUSA
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
$ 37.93 -2.19 % $ 3.01 B Nasdaq Global Select Market canadaCanada
Xeris Pharmaceuticals Xeris Pharmaceuticals
XERS
$ 16.95 0.92 % $ 2.72 B Nasdaq Global Select Market usaUSA
22nd Century Group 22nd Century Group
XXII
$ 0.38 -14.05 % $ 69.9 K NYSE American usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
- - $ 2.81 B Nasdaq Global Select Market,SPB usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
- - $ 1.94 B Nasdaq Capital Market canadaCanada
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
- - $ 532 M Nasdaq Global Select Market britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
- - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
- 0.52 % $ 821 M Nasdaq Global Select Market danmarkDanmark
Zogenix, Inc. Zogenix, Inc.
ZGNX
- -4.97 % $ 664 M Nasdaq Global Market,SPB usaUSA
Yunhong International Yunhong International
ZGYH
- 0.10 % $ 92.2 M Nasdaq Capital Market chinaChina
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
- -7.58 % $ 264 M Nasdaq Global Select Market usaUSA
Taysha Gene Therapies Taysha Gene Therapies
TSHA
$ 3.99 -0.25 % $ 1.28 B Nasdaq Global Select Market usaUSA
Zentalis Pharmaceuticals Zentalis Pharmaceuticals
ZNTL
$ 1.38 -7.38 % $ 99.2 M Nasdaq Global Market usaUSA
Zoetis Zoetis
ZTS
$ 85.52 2.44 % $ 37.9 B NYSE,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.